Literature DB >> 1572640

Application of an allele-specific polymerase chain reaction to the direct determination of ABO blood group genotypes.

L Ugozzoli1, R B Wallace.   

Abstract

The allele-specific polymerase chain reaction (ASPCR) procedure has proven a powerful tool for the detection and analysis of known genetic polymorphisms. Here, we present a novel application of the ASPCR technique to determine the ABO genotypes of individuals without the need of family analysis. The method introduces a new strategy for primer design that permits the identification of the different ABO genotypes according to the molecular size of allele-specific amplification products. Four primer sets, each specific for a different set of ABO alleles, are mixed in one reaction and the amplification products are resolved on a polyacrylamide gel. Forty-one individuals belonging to various families, whose ABO phenotypes were previously determined serologically, were typed with this new variation of the ASPCR technique. A 100% correlation between the serology and the ASPCR data was found. The Mendelian segregation of ABO alleles was also demonstrated in families. The method is rapid, simple, reproducible, and specific. Potential applications include gene mapping, genetic disease diagnosis, HLA typing, paternity testing, and forensic science.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572640     DOI: 10.1016/0888-7543(92)90292-z

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  12 in total

1.  PCR candidate region mismatch scanning: adaptation to quantitative, high-throughput genotyping.

Authors:  M Beaulieu; G P Larson; L Geller; S D Flanagan; T G Krontiris
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

2.  Identification of FAD2 and FAD3 genes in Brassica napus genome and development of allele-specific markers for high oleic and low linolenic acid contents.

Authors:  Qingyong Yang; Chuchuan Fan; Zhenhua Guo; Jie Qin; Jianzhong Wu; Qingyuan Li; Tingdong Fu; Yongming Zhou
Journal:  Theor Appl Genet       Date:  2012-04-26       Impact factor: 5.699

Review 3.  Forensic medicine and the polymerase chain reaction technique.

Authors:  R Decorte; J J Cassiman
Journal:  J Med Genet       Date:  1993-08       Impact factor: 6.318

4.  ACKR1 Alleles at 5.6 kb in a Well-Characterized Renewable US Food and Drug Administration (FDA) Reference Panel for Standardization of Blood Group Genotyping.

Authors:  Kshitij Srivastava; Pavel P Khil; Emilia Sippert; Evgeniya Volkova; John P Dekker; Maria Rios; Willy A Flegel
Journal:  J Mol Diagn       Date:  2020-07-17       Impact factor: 5.568

5.  Allele frequencies and molecular genotyping of the ABO blood group system in a Kuwaiti population.

Authors:  Suzanne Al-Bustan; Mokhtar El-Zawahri; Daleil Al-Azmi; Abdul-Aziz Al-Bashir
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

6.  Extensive polymorphism of ABO blood group gene: three major lineages of the alleles for the common ABO phenotypes.

Authors:  K Ogasawara; M Bannai; N Saitou; R Yabe; K Nakata; M Takenaka; K Fujisawa; M Uchikawa; Y Ishikawa; T Juji; K Tokunaga
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

7.  Allelic Prevalence of ABO Blood Group Genes in Iranian Azari Population.

Authors:  Mohammad Nojavan; Karrim Shamsasenjan; Ali Akbar Movassaghpour; Parvin Akbarzadehlaleh; Seyd Esmail Torabi; Morteza Ghojazadeh
Journal:  Bioimpacts       Date:  2012-06-25

8.  Molecular genotyping and frequencies of A1, A2, B, O1 and O2 alleles of the ABO blood group system in a Kuwaiti population.

Authors:  Mokhtar M El-Zawahri; Yunus A Luqmani
Journal:  Int J Hematol       Date:  2008-02-05       Impact factor: 2.490

9.  Ribonucleic acid (RNA) biosynthesis in human cancer.

Authors:  Omar S Hajjawi
Journal:  Cancer Cell Int       Date:  2015-02-21       Impact factor: 5.722

Review 10.  Evolution of technology for molecular genotyping in blood group systems.

Authors:  Ajit Gorakshakar; Harita Gogri; Kanjaksha Ghosh
Journal:  Indian J Med Res       Date:  2017-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.